Drug
Liposomal amphotericin B clinical trials
A product of Amphotericin B; its studies count on that page too.
- studies test it
- 53
- open now
- 6
- in phase 3
- 16
- first study started
- 1997
Keep track of what changes. Save the liposomal amphotericin B studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- AmBisome
- 28
Development codes
Studies by the year they started
50 studies that test it; most in 2007 (6); 1 more planned to start later
| Year | Studies |
|---|---|
| 1997 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2014 | 3 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 17
- Phase 3
- 16
- Phase 4
- 14
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 38
Gilead Sciences (8) · Drugs for Neglected Diseases (5) · Banaras Hindu University (5) · Hospital Universitário Professor Edgard Santos (2) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (2) · Poitiers University Hospital (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Sohag University (1)
Often tested with
Tested in the same studies.
Miltefosine (7) · Paromomycin (5) · Caspofungin (2) · Olorofim (1) · Sargramostim (1) · Voriconazole (1) · Fluconazole (1) · Multimodality Therapy (1)
Studies
Open first, then newest update. How each study uses liposomal amphotericin B is read from its arms, and is right about nine times in ten.
Testing it · 53
- Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)Not yet recruitingPhase 3Duke UniversityNCT06525389Written as Liposomal Amphotericin B (LAmB)
- Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)Not yet recruitingPhase 3Institute of Tropical Medicine, BelgiumNCT07463040Written as Liposomal Amphotericin B (LAmB)
- Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic DysfunctionNot yet recruitingNot applicableSoutheast University, ChinaNCT07337720Written as LIposomal amphotericin B (L-AmB) treatment
- Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated TalaromycosisNot yet recruitingNot applicableShanghai Public Health Clinical CenterNCT06926569Written as AmBisome
- Chronic Pulmonary Aspergillosis and Ambisome Aerosol with ItraconazoleRecruitingPhase 3Poitiers University HospitalNCT03656081Written as inhaled Ambisome®
- Treatment of Mucosal Bolivian LeishmaniasisRecruitingPhase 3Fundacion Nacional de DermatologiaNCT04799236Written as Group 3: Liposomal amphotericin B
- Olorofim Aspergillus Infection StudyCompletedPhase 3F2G LtdNCT05101187Written as AmBisome®
- Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis TreatmentCompletedPhase 2Assistance Publique - Hôpitaux de ParisNCT00467883Written as Liposomal Amphotericin B
- Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution WorkingActive, not recruitingPhase 2/3Sohag UniversityNCT06980493Written as Amphotericine in liposome (Ambisome®)
- Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the ElderlyCompletedPhase 1/2Hospital Universitário Professor Edgard SantosNCT06449040Written as Liposomal amphotericin B (AmBisome®)
- Bioequivalence of Amphotericin B Liposome for InjectionCompletedPhase 1CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT05913921Written as AmBisome
- Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study)CompletedPhase 1Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalNCT04267497Written as Amphotericin B Liposomal 50 MG
- Pharmacokinetics and Safety of AmBisome and DKF-5122CompletedPhase 1Dongkook Pharmaceutical Co., Ltd.NCT05749380Written as AmBisome
- A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy SubjectsCompletedPhase 1CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT04993222Written as AmBisome®
- Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)CompletedPhase 4Radboud University Medical CenterNCT02320604Written as Administration of study drug
- Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).CompletedPhase 2Poitiers University HospitalNCT02273661Written as Liposomal amphotericin B (Ambisome®)
- Short Course Regimens for Treatment of PKDL (Sudan)Status unknownPhase 2Drugs for Neglected DiseasesNCT03399955Written as Ambisome
- Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in BangladeshCompletedPhase 4Medecins Sans Frontieres, NetherlandsNCT03311607Written as AmBisome
- Antifungal Locks to Treat Fungal-related Central Line InfectionsCompletedPhase 4Bill McGheeNCT00936910Written as amphotericin B liposomal (Ambisome)
- Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in BrazilTerminatedPhase 4University of BrasiliaNCT01310738Written as Liposomal amphotericin B
See all 53 studies that test liposomal amphotericin B →
Given in every arm · 3 — liposomal amphotericin B is usual care beside what is tested
- Amphotericin Versus Posaconazole for Pulmonary MucormycosisCompletedPhase 2Post Graduate Institute of Medical Education and Research, ChandigarhNCT05468372Written as Liposomal Amphotericin B
- The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) StudyCompletedPhase 2Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterNCT00419770Written as Liposomal amphotericin B
- Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.CompletedPhase 3Drugs for Neglected DiseasesNCT02011958Written as Liposomal Amphotericin B
As the comparator · 7 — what is tested is compared with liposomal amphotericin B
- Antifungal Drugs in Pulmonary MucormycosisNot yet recruitingPhase 4Bin CaoNCT06756191Written as Liposomal Amphotericin B
- Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the ElderlyRecruitingPhase 2/3University of BrasiliaNCT06040489Written as Liposomal Amphotericin B
- A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral LeishmaniasisCompletedPhase 2Drugs for Neglected DiseasesNCT05593666Written as AmBisome®
- Liver Transplant European Study Into the Prevention of Fungal InfectionCompletedPhase 3Astellas Pharma IncNCT01058174Written as liposomal amphotericin B
- Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaCompletedPhase 3Astellas Pharma IncNCT00106288Written as Liposomal Amphotericin B
- Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant RecipientsCompletedPhase 4Fundacion SEIMC-GESIDANCT01303549Written as Liposomal amphotericin B
- To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala AzarCompletedPhase 3Bharat Serums and Vaccines LimitedNCT00876824Written as Liposomal Amphotericin B
Codes
What other systems call liposomal amphotericin B · ClinicalTrials.gg INT003564
- MeSH (NLM) C068538liposomal amphotericin BOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C068538 | liposomal amphotericin B | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.